Drugs in Palliative Care
While palliative care has adopted a holistic approach to treatment, medication driven symptom management ostensibly forms the critical aspect of care. Pharmacological therapy can be extremely complex because these patients often have co-existing medical conditions in addition to symptoms caused by their terminal disease. The resulting polypharmacy can be daunting for professionals and can negatively impact on effectiveness of care. The practitioner requires a simple, easy to navigate reference source that provides succinct and pertinent drug information. This detailed yet concise handbook will appeal to a variety of healthcare professionals involved in the provision of palliative care and medicines information. It begins with an overview of pharmacology and prescribing advice then contains over 100 entries of palliative care drugs, in an easy to use A-Z format.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
24 hours Additional information administration advised alfentanil analgesic antagonized antidepressants BTcP cancer Capsule caution in patients clinical significance Constipation Contraindications and precautions CrCl CSCI cyclizine daily dexamethasone diabetes Diarrhoea disease Dizziness dosage Dose adjustments Elderly drive or operate Drowsiness Drug interactions Drug interactions Pharmacokinetic duloxetine effects The frequency effects Very common end cover excreted fentanyl guidance is available haloperidol Headache hepatic impairment Hepatic/renal impairment hypertension hypoglycaemia hypokalaemia Hyponatraemia hypotension impairment see Dose increased as necessary increased risk inhibition Initial dose Injection insulin levomepromazine liver lowest effective dose maximum metabolized by CYP3A4 methadone midazolam modify reactions morphine NSAIDs ofthe operate machinery opioid oxycodone pain palliative palliative care Pharmacodynamic Pharmacokinetic Pharmacology plasma concentrations potential for interactions reactions and patients receptors reduced renal impairment reported undesirable effects serotonin syndrome severe hepatic impairment severe renal impairment significance of co-administration symptoms therapy titrated toxicity tramadol treatment ulcer undesirable effects include unknown weeks